LevEllis
Asheville, US · Founded 2024 · North Carolina LLC · 8 employees on LinkedIn
Find your way into LevEllis
55 people in our graph share verified history with the LevEllis team — schools, employers, funds. One of them is your warm intro.
LevEllis develops PROVOQUE, a topical facial serum built on the complete skin-specific secretome (growth factors, exosomes, and fetuin-A) sourced from skin progenitor cells. The company operates in regenerative aesthetics and skincare, offering a science-based product for aesthetic medicine and skin health.
Founders & leadership
LevEllis was founded in 2024 by Laura Ellis and Hans Keirstead.

Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 1 round · 2024
▶$1.1MraisedJun 2024 · 6 investors · OtherRule 506(b)
- Wesley Hayden LevExecutive Officer, Director
- Laura Burton EllisExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.1M
- Minimum investment
- $100K
- First sale
- Jun 2024
- Incorporated
- Limited Liability Company, North Carolina, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCompanies competing with LevEllis for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does LevEllis do?
- LevEllis develops PROVOQUE, a topical facial serum built on the complete skin-specific secretome (growth factors, exosomes, and fetuin-A) sourced from skin progenitor cells. The company operates in regenerative aesthetics and skincare, offering a science-based product for aesthetic medicine and skin health.
- Who founded LevEllis?
- LevEllis was founded by Laura Ellis, Hans Keirstead in 2024.
- How much funding has LevEllis raised?
- LevEllis has disclosed $1.1M raised across 1 round.
- Where is LevEllis headquartered?
- LevEllis is headquartered in Asheville, US.


